Company / Current Liabilities
Beta Bionics, Inc. Current Liabilities History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$30.9M
FY2025
5-year range
$10.6M / $30.9M
FY2023-FY2025
Trend
+46.2%
vs FY2024
Sector context
#152 of 160
Health Care
What the data says
Among 160 Health Care companies, Beta Bionics, Inc. is in the top 5% for current liabilities. Increased from $11M to $31M over the past 2 years.
Based on SEC 10-K filings.
$31M in FY2025.
Increased from $11M to $31M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 160This company $30.9M Sector average $4.5B
▼
-99.3% below sector average
Key checks
Key Insights
- In FY2025, current liabilities increased 46.2% year-over-year.
- Ranks #152 out of 160 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $30.9M | +46.2% |
| FY2024 | $21.1M | +99.4% |
| FY2023 | $10.6M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026